baber/WOPTO huggingface dataset:
Patent JP-2001507032-A (JP)
IPC: C11D17/04
Filed: 1997-12-17
Abstract: A packaged personal cleansing product comprising: (i) a foaming composition, wherein the foaming composition comprises less than 25% by weight, preferably less than 15% by weight, of water, at least 18% by weight of surfactant, wherein the surfactant comprises an anionic surfactant selected from alkyl glyceryl ether sulfonates, methyl acyl taurates, fatty acyl glycinates, N-acyl glutamates, acyl isethionates, acyl ethoxylated isethionates, acyl short chain branched isethionates, paraffin sulphonates, alpha-olefin sulphonates, fatty amide ethoxylated carboxylates, alkyl sulfosuccinates, alkyl ethoxysulphosuccinates, alpha-sulfonated fatty acids, their salts and/or their esters, alkyl phosphate esters, ethoxylated alkyl phosphate esters, acyl sarcosinates, and mixtures thereof, (ii) propellant gas; and (iii) a container for (i) and (ii); characterised in that the propellant gas comprises carbon dioxide, nitrous oxides, or mixtures thereof and that the viscosity of the foaming composition, measured at 20° C. and 1 atmosphere, using a Brookfield viscometer, No.2 Spindle at 60 rpm, is less than 700 mPa.s. The packaged personal cleansing product of the present invention provides improvided lathering, mildness, improved deposition of skin/hair care ingredients onto the skin and improved perfume delivery and residuality.
Patent JP-2000513113-A (JP)
Title: エレクトロクロミック素子、同素子を具備する表示装置及びエレクトロクロミック層を製造する方法
IPC: G02F1/1524
Filed: 1998-03-12
Abstract: (57)【要約】
エレクトロクロミック素子（２０）は、基板（２８）と、タングステン酸化物、モリブデン酸化物、ニオブ酸化物、マンガン酸化物、並びに、ジルコニウム酸化物、或は、それらの組合せから成るグループから選択された金属酸化物に基づく厚みｄを有するエレクトロクロミック層（２５）とを備える。前記エレクトロクロミック層（２５）は、該エレクトロクロミック層（２５）内の酸素含有量が該層の前記厚みにわたって変化していることを特徴とする。好ましくは前記エレクトロクロミック層（２５）における酸素含有量の変化は、少なくとも２つの局所的最大と１つの局所的最小とを備える。好ましくは、前記エレクトロクロミック層（２５）は、複数の副次層（２５’，２５”，２５”’）から構成され、該エレクトロクロミック層（２５）における酸素含有量の変化が２つの副次層間の遷移箇所で主に生じている。好ましくは前記エレクトロクロミック層（２５）は金属酸化物のタングステン酸化物ＷＯ x を備える。前記エレクトロクロミック素子は表示装置の表示スクリーン上に提供され得る。エレクトロクロミック層（２５）を製造する方法が説明されている。
Patent JP-2001508419-A (JP)
Title: ５−ｈｔ受容体活性を有するスルホンアミド化合物
IPC: C07D405/06
Filed: 1997-12-15
Abstract: (57)【要約】
式Ｉ：
 ［式中、Ａは、メチレンまたは−Ｏ−であり；Ｂは、メチレンまたは−Ｏ−であり；ｇは、０、１、２、３または４であり；Ｕは、１個以上のアルキル基によって場合により置換されているアルキレン鎖であり；Ｑは、窒素原子を有する２価の基であり；かつＴは、アリール基またはヘテロアリール基である］の化合物およびその製剤学的に認容性の塩は、中枢神経系の疾患、例えば鬱病、不安、精神病（例えば分裂病）、遅発性ジスキネジー、パーキンソン病、肥満、高血圧、トゥーレット症候群、性機能障害、薬物中毒、薬物乱用、認知障害、アルツハイマー病、老人性痴呆、強迫行動、パニック発作、社会恐怖症、摂食障害および食欲不振、心血管障害および脳血管障害、非インスリン依存性糖尿病、高血糖症、便秘症、不整脈、神経内分泌系の疾患、ストレスならびに痙攣を治療するのに有用である。
Patent JP-H11507396-A (JP)
IPC: A61K8/34
Filed: 1997-01-27
Abstract: Use in a cosmetic composition to be applied to the skin or mucous or semi-mucous parts, of a polymeric system consisting of an aqueous dispersion of particles of a film-forming polymer which gives a film having a hardness of less than about 110.
Patent JP-2001511163-A (JP)
Title: ヘキサメチレンジアミンと２−アミノメチルシクロペンチルアミンを含有する混合物から２−アミノメチルシクロペンチルアミンを分離する方法
IPC: C07C209/84
Filed: 1998-01-17
Abstract: (57)【要約】
水の存在下において蒸留することにより分離を行なうことを特徴とする、ヘキサメチレンジアミンと２−アミノメチルシクロペンチルアミンを含有する混合物から２−アミノメチルシクロペンチルアミンを分離する方法。
Patent JP-2000507558-A (JP)
Title: Ｃｎｓ損傷についての新規な治療
IPC: A61P31/00
Filed: 1997-03-24
Abstract: (57)【要約】
脳に対するＣＮＳ障害の治療における１,４,５−置換イミダゾール化合物および組成物の使用。
Patent JP-2000508310-A (JP)
IPC: A61P9/06
Filed: 1997-04-04
Abstract: Phenylpiperazine derivatives having high affinity for the alpha1-adrenoreceptor and pharmaceutical compositions containing them. Also disclosed is a method of using the such derivatives to treat benign prostatic hyperplasia.
Patent JP-H11508665-A (JP)
Title: 燃料噴射装置
IPC: F02M59/36
Filed: 1996-12-11
Abstract: (57)【要約】
本発明は、電磁弁を有する燃料噴射装置であって、電磁弁の弁部材がその端部にプランジャ形可動子（３３）を備えており、このプランジャ形可動子の作業運動が、緩衝装置によって緩衝されるようになっており、この緩衝装置が、プランジャ形可動子（３３）によって制限された緩衝室（４０）から成っており、この緩衝室が、絞り（３９）を介して放圧室（４１）に向かって放圧されるように構成されている。
Patent JP-2001514550-A (JP)
IPC: H04L29/06
Filed: 1998-02-27
Abstract: Medical sensors (1 to 4) are connected to a processor (6) comprising a PC and modems (14 and 16). The modems are connected to respective low power transmitter/receivers (18 and 20) The transmitter/receivers (18, 20) communicate with corresponding receiver/transmitters (18', 20') connected to a long range transmitter/receiver such as a satellite communications link (22, 23, 24). An operator of the apparatus has a hands free headset comprising a microphone (7) and earpieces (8), and has a head-up display (10). An electronic camera may also be provided. Medical data from the sensors (1-4) and images from the camera (9) and voice signals from the microphone (7) are processed by the processor (6), and transmitted to a remote location (B), for use by a doctor having a corresponding processor and display to diagnose the condition of a patient. The doctor can talk to the operator to advise on the condition and treatment of the patient.
Patent JP-2001517256-A (JP)
Title: オリゴマー難燃剤添加物
IPC: C07C17/12
Filed: 1998-03-20
Abstract: (57)【要約】
脂肪鎖に結合したアリール基を含むオリゴマー臭素含有化合物を含む難燃剤について記載する。本発明の難燃剤と難燃助剤とを含む難燃剤組成物についても記載する。また、必要に応じて難燃助剤を組み合わせた本発明の難燃剤を含むポリマー組成物、並びに材料を耐火性にする方法についても記載する。
Patent JP-2001519042-A (JP)
IPC: G02B6/42
Filed: 1998-03-31
Abstract: The proximal connector includes a stainless steel cone-shaped ferrule enclosing a proximal end of the optic fiber element. The ferrule is inserted within a matching aperture of a receiving block which is also made of stainless steel. The matching shapes of the ferrule and the aperture of the receiving block ensure effective heat transference from the ferrule into the receiving block. Both ferrule and the aperture are axially symmetric such that any rotation of the proximal connector while inserted into the receiving block does not change the location of the entrance aperture of the optic fiber element. The proximal connector also includes a case having an indented ring. A ball plunger biasing mechanism is mounted within the aperture of the receiving block and is positioned for engaging with the indented ring only while the proximal connector is fully and securely inserted within the aperture. The plunger prevents accidental removal of the proximal connector while also providing a biasing force for ensuring solid contact between the cone-shaped ferule and the corresponding portions of the receiving block to further facilitate the heat conduction.
Patent JP-2000511357-A (JP)
Title: 基板のプラズマジェット処理装置
IPC: C23C16/50
Filed: 1997-05-30
Abstract: (57)【要約】
高いスループットで大きな基板をプラズマジェットにより処理するための装置が記載される。この装置は複数の基板を保持するための１つ若しくは複数のカルーセルを具備する。カルーセルは更に、回転軸Ｄａを有する回転可能な角ドライブと、角ドライブシャフトから半径方向に延びる複数のアームと、複数の回転可能な基板ホルダと、を具備し、各基板ホルダはアームの１つに接続され、各回転可能な基板ホルダは、回転可能な角ドライブの回転軸Ｄａから距離Ｒに配置された回転軸Ｈａを有する。カルーセル角ドライブはプラズマジェットに対する被処理基板のプログラム可能な動作を提供する。装置はプラズマジェットの断面形状を調節するための手段の付いたプラズマジェットジェネレータを含む。これは、容易に実行される動作範囲内のプログラムされたカルーセル速度関数により、大きな基板の均一な処理を可能とする。装置はまた、プラズマジェットを提供するプラズマジェットジェネレータと、プラズマジェットジェネレータを、第１カルーセルに隣接する第１位置Ｚ 1  から第２カルーセルに隣接する第２位置Ｚ 2  に移動するための手段を提供する。第１カルーセル上の基板がプラズマジェットにより処理されている間、第２カルーセル上の基板はロード若しくはアンロードされることが可能となる。第１カルーセル上の基板の処理が完了すると、プラズマジェットは、第１位置Ｚ 1  から第２位置Ｚ 2  に移動される。
Patent JP-2001517284-A (JP)
IPC: F04D7/04
Filed: 1998-03-12
Abstract: The centrifugal liquid pump is of the rotary discs types and has an integrated gas injector of very single yet efficient structure. This pump has a casing defining an inner, substantially cylindrical chamber with an axial liquid inlet and a tangential liquid outlet. A rotary impeller is rotatably mounted within the chamber. This impeller has first and second spaced apart discs which are rigidly interconnected at such a distance away from each other as to extend close to the opposite walls of the chamber. The first disc that extends close to the wall into which the liquid inlet opens has a central opening of the same diameter as the liquid inlet to allow the liquid injected through the inlet to enter within the chamber in between the discs. The second disc has a plurality of spaced apart openings located at a constant radius, which is inferior to the radius of the discs. A coaxial power shaft is connected to the impeller so as to rotate it in a given direction. This shaft extends out of the chamber in a direction opposite to the liquid inlet. A gas feed pipe is in open communication with the chamber. This gas feed pipe is connected to a hole made in the casing. This hole is located in the second opposite wall of the chamber at a radial distance substantially equal to the above mentioned constant radius. In use, the pressurized gas fed through the hole made in second opposite wall of the casing passes through the openings made in the second disc and enters into the chamber. The gas is then disolved in the liquid while the same moves between the discs toward the outlet of the pump.
Patent JP-2002508680-A (JP)
IPC: A47C23/06
Filed: 1998-04-28
Abstract: PCT No. PCT/CH98/00171 Sec. 371 Date Nov. 22, 1999 Sec. 102(e) Date Nov. 22, 1999 PCT Filed Apr. 28, 1998 PCT Pub. No. WO98/52442 PCT Pub. Date Nov. 26, 1998A base of a bed having two parallel elastic longitudinal bars arranged at a distance from each other, and several grate-shaped cross slats. The ends of the cross slats are pushed into pockets which are fitted on the longitudinal bars, perpendicularly to the longitudinal direction. Each longitudinal bar has at least one fastening band which is fastened perpendicularly to the longitudinal direction and in the direction of the other longitudinal bar. The neighboring cross slat has a button for attaching the fastening band to the cross slat. This structure guarantees stable and non-aging fastening of the cross slats to the longitudinal bars with minimal means and the structure is also easy to assemble.
Patent MD-20000162-A (MD)
Title: Crystalline hydrate of 6-hydroxy-3-(4-[2-(piperidin-1-il)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophen hydrochloride, process for obtaining thereof, pharmaceutical composition containing it, use thereof for inhibition of pathological states and activation of choline acetyltransferase
Inventor: BUSH JULIE KAY
IPC: A61K45/00
Filed: 2000-07-28
Abstract: The present invention relates to pharmaceutical technology, particularly to a new crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-il)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophen hydrochloride, process for obtaining thereof and composition containing it. The problem which the present invention solves consists in obtaining a new crystalline form of arzoxifen not containing organic solvent in the crystalline network and which may be reproduced and effectively obtained on commercial scale.The crystalline hydrate of 6-hydroxy-3-(4-[2-(piperidin-1-il)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophen hydrochloride, F-1, is a compound having a high degree of crystallinity. The pharmaceutical composition containing the said compound also includes one or more carriers, diluents or sibstitutes, and, optionally, estrogen, progestin, aromatase inhibitor, LHRH analog and an acetylcholine esterase (AChE) inhibitor. The process for obtaining the above-mentioned compound provides for crystallization of 6-hydroxy-3-(4-[2-(piperidin-1-il)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophen hydrochloride of tetrahydrofuran.The compound may be used for inhibition of pathological states associated with estrogen deficiency, such as uterine fibrosis, endometriosis, proliferation of aortal, smooth muscular cells, restenosis, estrogen-dependent cancer (including breast cancer and uterine cancer), prostate cancer, the prostate benign hyperplasia, osteoporosis, cardiovascular affection, hyperlipemia, disorders of the CNS and Alzheimer's disease, prevention of breast cancer and activation of choline acetyltransferase (ChAT).Claims: 16
Patent NZ-200172-A (NZ)
Title: Forming loop of flexible binding material around objects
Inventor: SAUER L P
IPC: B65B13/10
Filed: 1982-03-30
Abstract: An apparatus and method are disclosed for forming a loop of flexible binding about objects positioned seriatim in an object receiving station. The apparatus includes a chain loop driven around the object receiving station. While a previously bound first object is in the receiving station, the chain is driven in one direction to move carrier rollers on the chain so as to pull the trailing portion of a binding through a major portion of the locus of a closed path around the receiving station while the lead end of the binding is held adjacent the receiving station. Spaced portions of the binding are guided from the interior of the path around the receiving station to maintain the binding in the configuration spaced outwardly of the receiving station. Subsequently, the first bound object is removed from the receiving station and a second object is positioned therein. The guiding of the interior of the binding around the receiving station is terminated so as to permit the binding to contact the second object while further pulling the trailing portion of the binding to complete the closed path and then form a tensioned loop about the second object.
Patent NZ-210638-A (NZ)
Title: Amino acid solutions
Inventor: RIGO J
IPC: C07C67/00
Filed: 1984-12-19
Abstract: For the contracting States : BE CH DE FR GB IT LI LU NL SE 1. Amino acid solutions for children of low birth-weight, newborn babies at term and young infants, which solutions can be used orally, enterally or parenterally, and are characterized in that they contain essential amino acids, (thr, leu, ileu, val, met, phe, try, lys, his) and semi-essential amino acids (cys, tau, tyr) in a weight ratio between the essential and semi-essential amino acids and the total amino acids of 46 % to 63 % and in that they contain taurine in a quantity of 0.5 % to 0.7 % by weight relative to the total amino acids. For the contracting State : AT Process for the preparation of amino acid solutions for children of low birth-weight, newborn babies at term and young infants, which solutions can be used orally, enterally or parenterally, and is characterized in that several amino acids are mixed in such a way as to obtain solutions which contain essential amino acids (thr, leu, ileu, val, met, phe, try, lys, his) and semi-essential amino acids, in a weight ratio between the essential and semi-essential amino acids and the total amino acids of 46 % to 63 % and of taurine in a quantity of 0.5 % to 0.7 % by weight relative to the total amino acids.
Patent NZ-239801-A (NZ)
Title: 2-aminocarbonyl-1-thiocycloalk-1-ene derivatives as a biocidal agent.
Inventor: AUSTIN PETER WILLIAM
IPC: A01N47/48
Filed: 1991-09-16
Abstract: A compound of the formula <CHEM> in which R<1> and R<2> taken together represent a polymethylene chain having 3 or 4 carbon atoms, or a polymethylene chain having 3 or 4 carbon atoms substituted by at least one lower alkyl radical having 1 to 4 carbon atoms, R<3> is hydrogen, hydrocarbyl or substituted hydrocarbyl and X represents cyano, a group -SO3M or a group -S-R<4> where M is hydrogen or an alkali metal such as sodium and R<4> is hydrocarbyl or substituted hydrocarbyl. Typically R<1> and R<2> complete a cyclopentene ring, R<3> is alkyl such as methyl and X is a group -SO3Na. The compounds have microbiological activity.
Patent NZ-250666-A (NZ)
Title: Tablet coating apparatus; means for transferring and discharging coated tablets
Inventor: BERTA NORBERT I
IPC: A61K9/28
Filed: 1994-01-11
Abstract: Apparatus and method for coating products (10) with two colors including a first coating section, a second coating section and a side to side transfer device (318) for transferring products from the first to the second sections. The transfer device includes a pair of plate grippers (372,373) each having a movable upper jaw (374) and a movable lower jaw (375). The upper and lower jaws are each adapted to receive and retain a product carrier plate (50). The transfer device includes a cam follower (380) that precisely closes the upper and lower jaws so that carrier plates located in the jaws are positioned in registration with each other in order to clamp product between the plates and to maintain the product clamped in the plates while the grippers are transferred between the first and second conveyor guides (314). An unloading station includes breaker pins for breaking a seal that may be formed between the coating material applied in the first coating section and the carrier plates. At a discharge station the carrier plates are rotated to cause the product to fall to a collection bin. Clean out bars adapted to be extended through the carrier plates while the plates are in the rotated discharge position cause any product that may have adhered to the plate and any excess coating material on the plate to be removed. <IMAGE>
Patent NZ-253330-A (NZ)
Title: Peptides derived from human papilloma virus, and their use
Inventor: KAST WYBE MARTIN
IPC: A61K38/08
Filed: 1993-05-04
Abstract: A peptide comprising an amino acid sequence derived from a human papilloma virus (HPV) protein, wherein said amino acid sequence has the ability to bind to a human Major Histocompatibility Complex Class I molecule. Its use in prophylactic or therapeutic treatment of cervical carcinoma and other HPV-related diseases.
Patent NZ-278937-A (NZ)
Title: Hepatitis b surface antigen protein mutant and its use
Inventor: KARAYIANNIS PETER
IPC: G01N33/576
Filed: 1995-02-02
Abstract: PCT No. PCT/GB95/00208 Sec. 371 Date Dec. 28, 1995 Sec. 102(e) Date Dec. 28, 1995 PCT Filed Feb. 2, 1995 PCT Pub. No. WO95/21189 PCT Pub. Date Aug. 10, 1995A variant or so-called "escape mutant" HBsAg protein or fragment thereof displaying the antigenicity of hepatitis B virus surface antigen is disclosed, in which the mutant protein or fragment thereof (mHBsAg) comprises a modified 'a' determinant in which at least two amino acids are inserted downstream of position 122 of the wild type HBsAg sequence. A vaccine comprising the mHBsAg is provided, as is a kit for diagnostic in vitro detection of anti-mHBsAg antibodies and an antibody preparation comprising anti-mHBsAg antibodies.
Patent NZ-314672-A (NZ)
Title: Combustion power tool piston retainer
Inventor: VELAN GEORGE M
IPC: B25C1/08
Filed: 1997-04-24
Abstract: A combustion powered tool (10) for driving fasteners into a workpiece includes a main housing (12) enclosing a cylinder body (14) and an adjacent combustion chamber (42). The tool includes a workpiece-contacting nosepiece (20) attached to the housing (12) at the end (22) opposite the combustion chamber (42) and holds fasteners to be driven into the workpiece. A reciprocally disposed piston (56) is mounted within the cylinder body (14), and is attached to an elongate driver blade (58) which is used to impact the fasteners and drive them into the workpiece. At the upper end (24) of the cylinder body (14) is disposed a compressible piston retaining device (98, Fig. 4; 168, Fig 7). The retaining device is of sufficient strength to accommodate the weight of the piston (56) and to retard the upward velocity of a returning piston (56), but is overcome when the tool (10) is fired. <IMAGE>
Patent NZ-321902-A (NZ)
Title: Method of producing alpha 2,3-sialyltransferase
Inventor: JACKSON RONALD JAMES
IPC: C12R1/91
Filed: 1996-11-15
Abstract: method of preparation of lysate having a2,3-sialyltransferase activity is disclosed. A cell culture having essentially no endogenous expression of eukaryotic a2,3-sialyltransferase is infected with myxoma virus. The harvested triton lysates include significant quantities of a protein having eukaryotic a2,3-sialyltransferase activity. Compositions having in vitro a2,3-sialyltransferase activity and comprising a protein extract of lysates of the aforementioned lysates are also provided for.  Divisional filed as 336246
Patent NZ-322467-A (NZ)
Title: Use of epinastine in the treatment of pain
Inventor: JUNG BIRGIT
IPC: A61K31/40
Filed: 1996-11-13
Abstract: he present invention relates to the use of epinastine  (3-amino-9, 13b-dihydro-1H-dibenz[c,f]imidazo [5,1-a]azepine hydrochloride) as the racemate or in the form of its enantiomers present as free base or as an addition salt with a pharmacologically acceptable acid in the manufacture of a medicament for the treatment of pain like migraine, Bing-Horton syndrome, tension headache, muscular pains, inflammatory pain or neuralgias. The use of epinastine can be used also in conjunction with another analgesic.  Divisional filed as 500549
Patent NZ-324431-A (NZ)
Title: Apparatus,in particular, a bed, for handling incapacitated patients
Inventor: BETSON SIMON
IPC: A61G7/00
Filed: 1996-12-06
Abstract: An apparatus for handling incapacitated patients is disclosed in one presently preferred embodiment of the present invention as including a bed (1) having a base frame (2) which supports a central panel (5) for supporting the patient's bottom, a second panel (8) and a third panel (9) for supporting the upper and lower parts, respectively, of the patient's legs and a fourth panel (6) for supporting the patient's back, there being drive means for displacing the panels such that in one configuration their upper surfaces lie in a single horizontal plane and in another configuration adjacent panels are inclined with respect to each other, characterized in that the apparatus further includes a leg support (12) which is displaceable into and out of a position in which it forms a local widening of the bed (1), in which position it can support the lower parts of the patient's legs when the patient is in an attitude in which the legs are straight or are bent and the patient is lying on his side, and further characterized by a patient support (250) having a seat portion and a back portion, the patient support (250) being supported by the bed (11), the apparatus being such that when the patient is in said attitude said seat portion may be interposed between the patient's bottom and upper parts of the legs, on the one hand, and the second panel (8) when upright, on the other hand, with the back portion of the patient support (250) adjacent the patient's back, and the fourth panel (6) may be brought upright by said drive means to cause the patient to adopt a sitting position on the patient support (250).
Patent NZ-336782-A (NZ)
Title: A system for electronic publishing, predefined portions of data encoded with linking means
Inventor: SCHNELLE CHRISTOPH
IPC: G06F17/21
Filed: 1998-01-30
Abstract: system for publishing electronic information includes predefined portions of data, with each predefined portion being encoded with at least one linking means.  Each predefined portion is stored, and where a predefined portion has been modified, each modified portion predefined portion is stored.  The system also has attributes, which are points on an axis of a multidimensional space for organizing the data.  The predefined portions of data may be encoded using SGML or XML.  The data may also be encoded using one or more Document Type Definitions (DTD) or Style Sheet Mechanisms (SSM).
Patent NZ-500703-A (NZ)
Title: Preparation of food-grade marine edible oils by treatment with silica, vacuum steam deodorisation and addition of a herb extract
Inventor: KENDRICK ANDREW
IPC: B01D15/00
Filed: 1999-10-29
Abstract: Food-grade marine oil is stabilized by treatment with silica in the presence or absence of carbon, vacuum steam deodorisation at a temperature between about 140°C and about 210°C in the presence of 0.1-0.4% by weight deodorized rosemary or sage extract.  If desired 0.01-0.03% by weight ascorbyl palmitate and 0.05-0.2% by weight mixed tocopherol can be added.
Patent NZ-510433-A (NZ)
Title: Compositions containing diphosphonic acids as an inner phase and stearic acid as the outer phase
Inventor: WOOG HEINRICH
IPC: A61K31/663
Filed: 1999-10-01
Abstract: A pharmaceutical composition in solid unit dosage form comprises an inner phase containing 0.25-100 mg of diphosphonic acid or a physiologically compatible salt thereof as the active ingredient and an outer phase containing stearic acid in an amount of less than 5% by weight of the dosage form.